Article
Biomarkers of HIV-1 associated dementia: proteomic investigation of sera
17 Mar 2009
Abstract excerpt
BACKGROUND: New, more sensitive and specific biomarkers are needed to support other means of clinical diagnosis of neurodegenerative disorders. Proteomics technology is widely used in discovering new biomarkers. There are several difficulties with in-depth analysis of human plasma/serum, including that there is no one proteomic platform that can offer complete identification of differences in proteomic profiles....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
